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Abstract Two-dimensional gel electrophoresis was used to 
identify polypeptides differentially expressed between normal 
and c-jun transformed rat fibroblasts. The level of a 49 kDa 
polypeptide was 3-fold elevated in c-jun transformed cells. 
Sequence analysis by ion trap mass spectrometry identified the 
polypeptide as rat a-enolase. Enolase functions as a cell surface 
receptor for plasminogen, suggesting that upregulation may 
increase plasminogen activation and cell surface proteolysis 
important for tumor growth. However, no difference was 
observed between normal and transformed cells in formation of 
plasmin, suggesting that upregulation of a-enolase may con-
tribute to an increased metabolic capacity, but not to increased 
plasminogen activation. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
c-Jun is the major component of the AP-1 transcription 
factor. The activity of c-Jun is regulated by serine/threonine 
phosphorylations, triggered by activation of receptor Tyr kin-
ases, Src-family kinases and H-Ras [1,2]. Overexpression of c-
Jun induces transformation of rat fibroblasts [3]. 
Little is known about c-Jun target genes and the outcome 
of signal transduction pathways acting via c-Jun. Decreased 
expression of cellular matrix proteins has been reported in c-
jun transformed cells and in ras-oncogene transformed cells 
[4]. Ras transformed cells show invasive characteristics [5,6], 
and have been shown to overexpress metalloproteases and 
urokinase plasminogen activator [7,8]. 
For some cells, binding of plasminogen is rate-limiting for 
cell surface mediated activation of plasminogen by urokinase 
[9]. Plasminogen receptors are present in large numbers and 
show relatively low affinity for plasminogen. The receptors 
recognize the lysine binding sites associated with the kringle 
domains of plasminogen [9]. Proteins with carboxyl-terminal 
lysine residues such as a-enolase and annexin II show plasmi-
nogen binding activities [10]. Plasminogen binding to cells 
enhances plasmin activity by augmenting plasminogen activa-
tion, and protecting plasmin from inactivation by inhibitors 
[10]. 
"■Corresponding author. Fax: (46) (8) 337462. 
In this study, we have used two-dimensional gel electropho-
resis to screen for genes differentially expressed between nor-
mal and c-jun transformed fibroblasts. A 49 kDa protein over-
expressed in transformed cells was identified by electrospray 
collision induced dissociation ion trap mass spectrometry of 
its tryptic peptides. The functional significance of this protein 
was examined with regard to reports showing that it is a cell 
surface plasminogen receptor. 
2. Materials and methods 
2.1. Cell lines and reagents 
FR3T3 is an immortalized rat fibroblast cell line [11]. Junl and 
Jun3 were derived from FR3T3 by transfection with a human c-jun 
cDNA expression vector [4]. FR3T3-RAS was derived from FR3T3 
by transfection with T24-H-ras. 
Human Glu-plasminogen was prepared by affinity chromatography 
of plasma on lysine-Sepharose [12]. Human one-chain tissue plasmi-
nogen activator was purified from melanoma cell cultures [13]. Flavi-
gen-Pli (2AcOH. H-D-But-CHT-lys-PNA) was obtained from Biopool 
(Umeâ, Sweden). Resolyte (pH 4-8) was from BDH, Poole, UK. 
2.2. Peptide synthesis 
Peptides were synthesized with Fmoc chemistry using an Applied 
Biosystems 430A peptide synthesizer. Cleavage of the peptide from 
the resin and removal of the side chain protecting groups were carried 
out using reagent K. The peptides were purified by HPLC on Vydac 
C-8 with a gradient of acetonitrile in 0.05% aqueous TFA, and their 
masses were confirmed by electrospray ionization mass spectrometry 
on a Finnigan-MAT TSQ 7000. 
2.3. Plasminogen activation assay 
Cells were non-enzymatically detached in Cell Dissociation Solution 
(Gibco, Paisley, UK) for 15 min at 37°C. Cells were counted in a 
hemocytometer and resuspended in 0.1 M Na-phosphate, pH 7.3. 
The cell suspension was added to quartz or plastic microtiter plates 
and reagents were added to final concentrations of 0.3 uM plasmino-
gen, 0.4 nM tPA and 400 u.M Flavigen-Pli in a volume of 250 ul. 6-
Aminohexanoic acid (e-aminocaproic acid ; EACA) was added, where 
indicated, to a final concentration of 40 mM. All samples were run in 
duplicate. Plates were incubated at 30°C, and the absorbance at 450 
nm was monitored every 5 min in a 2001 Anthos (Salzberg, Austria) 
microplate reader. 
2.4. Two-dimensional electrophoresis and image analysis 
Cells were labelled with [35S]methionine for 16 h in methionine-free 
medium containing 5% fetal calf serum. Cell extracts were prepared as 
described [14]. Two-dimensional gel electrophoresis [15,16] utilized 
Resolyte (2%, pH 4-8) for isoelectric focusing, and 10-13% gradient 
SDS polyacrylamide gels for the second dimension. Gels were dried 
and exposed to X-ray film, or stained with Coomassie brilliant blue 
for subsequent in-gel digestion of protein spots. 
Autoradiography films were scanned at 100 um resolution using a 
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Molecular Dynamics laser densitometer. Data were analyzed using the 
PDQUEST software [17] (Pharmacia Biotech AB). Background was 
subtracted, peaks located and the individual polypeptide quantities 
were expressed as ppm of the total integrated optical density. 
2.5. In-gel digestion and mass spectrometric sequence analysis 
Gel pieces were excised and destained by end-over-end mixing in 12 
ml 30% methanol for 48 h (room temperature), washed twice for 30 
min with 150 ml of 1:1 acetonitrile/0.1 M ammonium bicarbonate, pH 
8. The washed gel pieces were dried in Eppendorf tubes in a Savant 
Speed Vac. 
Rehydration of gel pieces, with 0.1 M ammonium bicarbonate, pH 
8, containing 0.2 |ig/ul (8 pmol/ul) trypsin (modified trypsin from 
Boehringer Mannheim, dissolved in 1 mM HC1 and stored at 
—20°C in aliquots until use), was achieved in a volume just enough 
to cover the pieces. Additional buffer without trypsin was added if 
necessary. After incubation at 37°C for 20 h, the condensate was 
collected by spinning the tubes briefly and excess liquid was removed 
into a new Eppendorf tube. Peptides remaining in the gel matrix were 
extracted with 150 ul 60% aqueous acetonitrile, 0.1% formic acid at 
30°C for 30 min. The combined extracts were dried under a stream of 
nitrogen. 
All mass spectrometric data regarding tryptic peptides from in-gel 
digestions were obtained from collision induced dissociation (CID) 
spectra with a Finnigan-MAT LCQ ion trap mass spectrometer after 
introduction via a polyamide coated fused silica microcapillary HPLC 
[18]. 
3. Results 
3.1. Overexpression of a 49 kDa protein in c-jun transformed 
FR3T3 cells 
Two-dimensional gel electrophoresis was used to screen for 
differences in protein expression between FR3T3 cells (an un-
transformed rat fibroblast cell line) and two c-jun transformed 
derivatives of FR3T3 (Junl and Jun3). Autoradiographs of 
[35S]methionine labelled polypeptides were scanned, and the 
images analyzed with the PDQUEST software [17]. 
Increased expression of two polypeptides with molecular 
weights of 46 kDa but with different p/s was observed in 
Junl (Fig. 1) and Jun3 cells (not shown). Quantitation by 
PDQUEST showed an approximately 3-fold increase of the 
major (basic) 49 kDa protein and an approximately 6-fold 
increase of the acidic protein. A number of other differences 
were also observed. The cytoskeletal proteins tropomyosin-2 
and -3 were down-regulated in c-jun transformed cells, where-
as proliferating cell nuclear antigen (PCNA) was upregulated 
(Fig. 1). 
The 49 kDa proteins were more prominently expressed in 
FR3T3-RAS cells, a derivative of FR3T3 cells which expresses 
12V-H-Ras (data not shown). 
3.2. Identification of the basic 49 kDa protein as a-enolase 
The major form of the 49 kDa protein was digested in the 
gel with trypsin and fragments were analyzed by electrospray 
CID ion trap mass spectrometry. The masses of the tryptic 
fragments (Table 1) showed 13 perfect matches to the pub-
lished sequence of rat a-enolase. All except peptide fragments 
8 and 11 were also verified by sequence interpretation from 
the CID spectra. 
3.3. Plasminogen activation by c-jun transformed and 
non-transformed cells 
Cells were incubated in the presence of plasminogen, tPA 
and a plasmin chromogenic substrate. The interactions of 
plasminogen and tPA with FR3T3 cells induced a cell con-
centration dependent increase in the rate of plasmin genera-
tion (Fig. 2A). Activation was inhibited by the lysine analogue 
EACA, and did not occur in the absence of tPA or plasmi-
nogen. 
Comparison of plasminogen activation by c-jun trans-
formed and parental FR3T3 cells (Fig. 2B) showed no differ-
ence in the efficiency of plasminogen activation in the presence 
of tPA. Junl cells, but not FR3T3 cells, showed weak but 
reproducible plasminogen activation in the absence of tPA. 
3.4. An a-enolase peptide does not inhibit plasminogen 
activation 
A peptide (C13) corresponding to a 13 residue C-terminal 
portion of a-enolase was added to Junl cells and the corre-
sponding 12 residue peptide lacking the C-terminal lysine res-
idue, desLys-C13, was also studied as a control (Fig. 2C). No 
effect on plasminogen activation was observed using either 
peptide. Note that a plastic microtiter plate was used for 
Fig. 1. Autoradiographs of two-dimensional gel separations of [35S]methionine labelled polypeptides from FR3T3 and Junl cells. The two 49 
kDa polypeptides found to be increased in c-jun transformed cells are encircled. TM, tropomyosin; PCNA, proliferating cell nuclear antigen. 
A.-C. Bergman et al.lFEBS Letters 417 (1997) 17-20 19 
B 
g °'4-
O FR3T3{C1) + tPA 
□ FR3T3(C2) + tPA 
• FR3T3(C1 ) + 1PA + EACA 
0 FR3T3(C3> + IPA 
g FR3T3{C1) - tPA 
^ FR3T3(C1) + tPA-F 
□ FR3T3 + tPA 
O Jun1 + tPA 
10000 20000 30000 40000 50000 60000 
C °'25i 
• Jun1 + C13 + tPA 
O Juni + desLysC13 +tPA 
□ Jun1 +(PA 
| tPA O C13 + tPA + desl_ysC13 + tPA 
© C13 + IPA + EACA 
O desLysC13 + tPA + EACA 
2500 5000 7500 10000 12500 15000 2500 5000 7500 10000 12500 15000 
TIME2 (SEC2) TIME2 (SEC2) 
Fig. 2. Cell dependent activation of plasminogen. Cells were incubated with tPA, plasminogen (PIG) and EACA as indicated. Plasmin activity 
was detected by following the cleavage of a chromogenic substrate (Flavigen Pli). The absorbance values were plotted as a function of time 
squared, and the slopes of the curves represent estimates of plasminogen activation rates. A: Various numbers of FR3T3 cells were added to a 
quartz microtiter plate (Cl: 5X104 cells; C2: 2xl04 cells; C3: 5X103 cells) in a 250 ul reaction. B: FR3T3 and Junl cells (3xl05 cells per 
well) were incubated in the presence or absence of tPA. A quartz microtiter plate was used. C: 2.5 X105 Junl cells were added to each well of 
a plastic microtiter plate, and incubated in the presence or absence of 30 |J,M peptide. Peptide C13 corresponds to the 13 C-terminal amino 
acids of rat a-enolase, peptide desLys-C13 was identical to peptide C13 except that it lacked the C-terminal lysine. D: Peptide C13 and 
desLys-C13 were added to glass wells and incubated overnight. After washing away excess peptide, plasminogen, tPA and Flavigen Pli were 
added. Note the activation of plasminogen by peptide C13 (13 C-terminal amino acids of rat a-enolase) and the inhibition by 40 mM EACA. 
this experiment, since the peptides adhered to the glass sub-
strate (see Fig. 2D). 
To examine whether the a-enolase C-terminus stimulates 
plasminogen activation, peptide 13C was immobilized on a 
glass surface. Peptide C13 stimulated plasminogen activation 
by tPA, and this stimulation was sensitive to EACA (Fig. 
2D). DesLys-C13 did not stimulate plasminogen activation. 
4. Discussion 
Using two-dimensional gel electrophoresis and ion trap 
mass spectrometry, we found that a-enolase expression was 
Table 1 
Mass analysis of tryptic fragments 
Peptide 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
MS found 
1648.0 
1406.6 
2738.1 
2610.0 
1961.1 
2047.2 
1805.1 
1439.5 
2209.2 
1929.0 
3024.4 
2368.5 
3046.2 
MS calculate 
1647.8 
1406.7 
2736.3 
2608.2 
1960.9 
2047.0 
1804.9 
1439.7 
2208.0 
1929.0 
3023.5 
2367.2 
3043.4 
T Residues" 
343-357 
15-27 
80-102 
81-102 
202-220 
306-325 
32^19 
269-280 
233-252 
162-178 
372-399 
372-393 
281-305 
"Based on rat a-enolase (SwissProt.r34 accession number: P04764). 
increased in c-jun and ras transformed fibroblasts. Recombi-
nant a-enolase binds plasminogen [19] and a-enolase is 
known to be a cell surface plasminogen receptor on some 
cell types [20,21]. The finding that a-enolase is upregulated 
in transformed cells raised the question whether cell-associ-
ated plasminogen activation is increased. Increased formation 
of plasmin at the cell surface would lead to increased proteol-
ysis, important for tumor cell invasion and metastasis. 
FR3T3 and Junl cells enhanced the activation of plasmi-
nogen to plasmin in the presence of tPA. This effect was 
inhibited by EACA, suggesting that binding of plasminogen 
to lysine residues on cell surfaces was necessary for enhance-
ment. However, no difference in stimulation of plasminogen 
activation by tPA was observed between FR3T3 cells and 
their c-jun transformed derivatives, and further experiments 
showed that a peptide corresponding to the C-terminal por-
tion of a-enolase also did not affect plasminogen activation by 
c-jun transformed cells. Together, these data suggest that a-
enolase is not an important plasminogen cell surface receptor 
on rat fibroblasts. Plasminogen receptors are characterized by 
their relatively low affinity and their exceptionally high density 
on many cells. It is possible, therefore, that changes in the 
levels of a single type of plasminogen receptor do not lead 
to detectable differences in cell-associated plasminogen activa-
tion. 
As expected [20,21], control experiments showed that im-
mobilized a-enolase C-terminal peptide stimulates plasmino-
gen activation by tPA. 
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J u n i cells, but not non-transformed FR3T3 cells, activated 
plasminogen in the absence of tPA. This result is consistent 
with reports showing that transformed fibroblasts express 
plasminogen activators [22]. 
Two-dimensional gel electrophoresis of proteins is a valua-
ble approach to studying changes in gene expression in bio-
logical systems. One disadvantage of this technique was diffi-
culties in monitoring changes in the expression of multiple 
polypeptides. This problem has been overcome by the avail-
ability of software such as P D Q U E S T [17] and Melanie II [23] 
which have made computer analysis of gel patterns possible. 
Another disadvantage was the difficulty of obtaining sequence 
information from the limited amounts of protein on the gels, a 
problem solved by the increased sensitivity of mass spectrom-
etry. We conclude from this study identifying ot-enolase that 
two-dimensional gel electrophoresis in combination with mass 
spectrometry can be used to rapidly identify changes at the 
translational and posttranslational levels. 
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